{"transactions":[{"id":4639763,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":109996,"kind":"person","name":"Olds Donald","position":1,"cik":"0001807762","reported_name":"Olds Donald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-10-13T22:11:52.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":5637,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5637},"source":{"system":"sec-edgar","filing":"0001213900-26-109158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026109158/ownership.xml","form_type":"4"}},{"id":4639762,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":109996,"kind":"person","name":"Olds Donald","position":1,"cik":"0001807762","reported_name":"Olds Donald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-13T22:11:52.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":5637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."}],"balance_after":5637,"source":{"system":"sec-edgar","filing":"0001213900-26-109158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026109158/ownership.xml","form_type":"4"}},{"id":4638340,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":109996,"kind":"person","name":"Olds Donald","position":1,"cik":"0001807762","reported_name":"Olds Donald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-09T01:39:23.000Z","date":"2026-10-08","kind":"grant","planned":false,"acquired":true,"shares":5636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on the first anniversary of the date of grant, with the remaining stock options vesting in 12 quarterly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on the first anniversary of the date of grant, with the remaining stock options vesting in 12 quarterly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":5636,"derivative":{"exercise_price":12,"expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":5636},"source":{"system":"sec-edgar","filing":"0001213900-26-108189","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026108189/ownership.xml","form_type":"4"}},{"id":1789349,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":109996,"kind":"person","name":"Olds Donald","position":1,"cik":"0001807762","reported_name":"Olds Donald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-09-05T15:54:48.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":381,"price":2.05,"value":781.05,"ownership":{"direct":true},"balance_after":381,"source":{"system":"sec-edgar","filing":"0001062993-23-017516","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807762/000106299323017516/form4.xml","form_type":"4"}},{"id":1827898,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":109996,"kind":"person","name":"Olds Donald","position":1,"cik":"0001807762","reported_name":"Olds Donald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-18T16:36:00.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal monthly installments over a period of 12 months."}],"balance_after":12500,"derivative":{"exercise_price":2.64,"expiration_date":"2033-07-14","underlying":"Class A Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001062993-23-014998","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807762/000106299323014998/form4.xml","form_type":"4"}},{"id":2148741,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":109996,"kind":"person","name":"Olds Donald","position":1,"cik":"0001807762","reported_name":"Olds Donald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-09-30T16:20:34.000Z","date":"2022-09-28","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Based on conversion of exercise price of C$0.80 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7321 on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on 09/28/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months."}],"balance_after":45000,"derivative":{"exercise_price":0.59,"expiration_date":"2032-09-28","underlying":"Class A Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001171843-22-006334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807762/000117184322006334/ownership.xml","form_type":"4"}},{"id":2510869,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":109996,"kind":"person","name":"Olds Donald","position":1,"cik":"0001807762","reported_name":"Olds Donald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-11-16T16:21:04.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":42100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Based on conversion of exercise price of C$2.05 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7959 on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on 11/12/2021 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable with respect to 25% of the shares every three months."}],"balance_after":42100,"derivative":{"exercise_price":1.63,"expiration_date":"2031-11-12","underlying":"Class A Common Shares","underlying_shares":42100},"source":{"system":"sec-edgar","filing":"0001171843-21-008011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807762/000117184321008011/ownership.xml","form_type":"4"}}]}